Neil Bloom - Cohen Assistant Treasurer
UTF Fund | USD 22.00 0.30 1.38% |
Mr. Neil Bloom is Assistant Treasurer of Cohen Steers Infrastructure Fund Inc. He joined the Advisor in 2008. Prior thereto, he was Senior Tax Manager at KPMG, LLC since 2004.
Age | 44 |
Phone | 212 832 3232 |
Web | https://www.cohenandsteers.com/funds/details/infrastructure-fund |
Neil Bloom Latest Insider Activity
Tracking and analyzing the buying and selling activities of Neil Bloom against Cohen fund is an integral part of due diligence when investing in Cohen. Neil Bloom insider activity provides valuable insight into whether Cohen is net buyers or sellers over its current business cycle. Note, Cohen insiders must abide by specific rules, including filing SEC forms every time they buy or sell Cohen'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Neil Bloom few days ago Insider Trading |
Cohen Management Performance (%)
The company has Return on Asset of 1.37 % which means that on every $100 spent on assets, it made $1.37 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 2.83 %, implying that it generated $2.83 on every 100 dollars invested. Cohen's management efficiency ratios could be used to measure how well Cohen manages its routine affairs as well as how well it operates its assets and liabilities.Similar Money Managers
Showing other executives | One Year Return | ||
Thomas Kent | Tekla Healthcare Investors | 67 | |
Christopher Flynn | Royce Value Closed | N/A | |
Michael Bonney | Tekla Healthcare Investors | 59 | |
John Denneen | Royce Value Closed | 53 | |
Lisa Curcio | Royce Value Closed | 60 | |
Rakesh Jain | Tekla Healthcare Investors | 69 | |
Laura Woodward | Tekla Healthcare Investors | 51 | |
Elizabeth Nabel | Tekla Healthcare Investors | 67 | |
Lauren CFA | Royce Value Closed | N/A | |
Uwe Reinhardt | Tekla Healthcare Investors | 79 | |
Peter Hoglund | Royce Value Closed | 54 | |
Christopher MBA | Tekla Healthcare Investors | N/A | |
Dr MS | Tekla Healthcare Investors | 71 | |
William Reardon | Tekla Healthcare Investors | 74 | |
Lucinda Stebbins | Tekla Healthcare Investors | 73 | |
Frank Gentile | Tekla Healthcare Investors | 62 |
Management Performance
Return On Equity | 2.83 | |||
Return On Asset | 1.37 |
Cohen And Steers Leadership Team
Elected by the shareholders, the Cohen's board of directors comprises two types of representatives: Cohen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cohen. The board's role is to monitor Cohen's management team and ensure that shareholders' interests are well served. Cohen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cohen's outside directors are responsible for providing unbiased perspectives on the board's policies.
James Giallanza, CFO, Principal Accounting Officer and Treasurer | ||
Lisa Phelan, Chief Compliance Officer | ||
Heather Kaden, Deputy Chief Compliance Officer | ||
Ramona RogersWindsor, Independent Director | ||
Daphne Richards, Independent Director | ||
Dean Junkans, Independent Director | ||
C Ward, Independent Director | ||
Joseph Harvey, Vice President, Director | ||
Robert Becker, Vice President | ||
Elaine ZaharisNikas, Vice President | ||
Jane Magpiong, Independent Director | ||
Adam Derechin, President, Chief Executive Officer | ||
Matthew Stadler, Executive Vice President CFO | ||
Robert Steers, Co-Chairman of the Board | ||
William Scapell, Vice President | ||
Albert Laskaj, Treasurer | ||
Frank Ross, Independent Director | ||
Francis Poli, Secretary | ||
Stephen Murphy, Chief Compliance Officer, Vice President | ||
Michael Clark, Lead Independent Director | ||
Dana DeVivo, Secretary, Chief Legal Officer | ||
Gerald Maginnis, Independent Director | ||
Yigal Jhirad, Vice President | ||
Richard Norman, Independent Director | ||
Edward Ward, Independent Director | ||
Richard Kroon, Lead Independent Director | ||
Neil Bloom, Assistant Treasurer | ||
Bonnie Cohen, Independent Director | ||
George Grossman, Independent Director | ||
Benjamin Morton, Vice President | ||
Tina Payne, Secretary and Chief Legal Officer |
Cohen Fund Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right fund is not an easy task. Is Cohen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 2.83 | |||
Return On Asset | 1.37 | |||
Profit Margin | 63.49 % | |||
Operating Margin | 68.92 % | |||
Current Valuation | 3.16 B | |||
Shares Outstanding | 93.72 M | |||
Shares Owned By Institutions | 17.00 % | |||
Number Of Shares Shorted | 178.19 K | |||
Price To Earning | 31.28 X | |||
Price To Book | 1.02 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Cohen And Steers. Also, note that the market value of any fund could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.